Browsing Category
Bio space
1985 posts
Kintor Pharmaceutical Announces Dosing of First Batch of Subjects in Phase I Clinical Trial of GT20029 in China
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company…
Taro Provides Results for Quarter Ended June 30, 2021
Taro Pharmaceutical Industries Ltd. provided unaudited financial results for the quarter ended June 30, 2021. Read More
Venus Medtech Appoints Professor Martin B. Leon as Global Principal Investigator of Its New-Generation RDN System
On July 27, 2021, Venus Medtech Inc., a leading provider of comprehensive interventional heart valve therapy solutions in…
Ascletis Announces Completion of 149 Patient Enrollment and Positive Interim Results of Phase IIb Chronic Hepatitis B Study in China for its Subcutaneously Administered PD-L1 Antibody ASC22 (Envafolimab)
The ASC22 Phase IIb study is a randomized, single-blind, placebo-controlled, multi-center clinical trial in China which evaluates the…
Relief Reports that its U.S. Collaboration Partner has Announced Emergency Use Authorization of Aviptadil in Nation of Georgia
RELIEF THERAPEUTICS Holding AG reported that the parent company of its collaboration partner, NRx Pharmaceuticals, Inc., reported in…
Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita
RELIEF THERAPEUTICS Holding AG announced that it has closed a definitive agreement to acquire all outstanding shares of…
Touchlight and Vanderbilt University Medical Center collaborate on DARPA Pandemic Prevention Platform programme to develop synthetic DNA-based antibody to protect against emerging threats
Touchlight, the leading synthetic DNA manufacturer, is collaborating with the Vanderbilt Vaccine Center at Vanderbilt University Medical Center…
ASC Therapeutics Announces Partnership With University of Massachusetts Medical School to Co-Develop Novel Gene Therapy for Maple Syrup Urine Disease
ASC Therapeutics, a privately-held biopharmaceutical company pioneering the development of transformative in-vivo gene replacement, gene editing and allogeneic…
Inceptor Bio Announces The Appointment Of Dr. Mark J. Gilbert As Chair Of Its Scientific Advisory Board
Inceptor Bio, a Research Triangle Park, North Carolina-based cell and gene therapy biotechnology company, announced the appointment of…
XPhyto’s Acquisition Target, 3a-Diagnostics, Reports Breakthrough Identification of COVID-19 Biosensor Candidates
XPhyto Therapeutics Corp. announces that its acquisition target, 3a-diagnostics GmbH has identified the first saliva activated “in-mouth” biosensor…
